NCT03530033

Brief Summary

In recent years, the application of intraoperative recurrent laryngeal nerve monitoring in thyroid surgery has greatly reduced the complications of recurrent laryngeal nerve injury. The use of intraoperative neurological monitoring requires the reduction of the dose of neuromuscular blockade, which often leads to muscle tremors during the application of electrical energy, which affects the fine separation around the muscles. This study explored the effect of local application of lidocaine on reducing muscle tremor during surgery and its optimal dose.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 8, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2018

Completed
Last Updated

September 18, 2018

Status Verified

September 1, 2018

Enrollment Period

6 months

First QC Date

May 8, 2018

Last Update Submit

September 17, 2018

Conditions

Outcome Measures

Primary Outcomes (5)

  • dose of muscle relaxant drugs

    dose of muscle relaxant drugs

    At the end of surgery

  • dose of lidocaine

    dose of lidocaine

    At the end of surgery

  • Number of nerve signal loss cases

    Number of nerve signal loss cases

    At the end of surgery

  • Anatomical time of accessory nerve

    Anatomical time of accessory nerve

    At the end of surgery

  • The satisfaction of sternocleidomastoid muscle separation

    The visual score was 5 points for the most satisfaction and 0 points for the most dissatisfied.

    At the end of surgery

Study Arms (2)

Conventional surgery group

NO INTERVENTION

Induction of anesthesia according to conventional neuromuscular blockade dose, no neuromuscular blockade drug maintenance during lateral neck dissection.

Lidocaine group

EXPERIMENTAL

Anesthesia induction was performed according to conventional nerve monitoring neuromuscular blockade doses and lateral neck dissection was performed. When local muscle tremors occur, lidocaine is injected locally to eliminate muscle tremors.

Drug: Lidocaine

Interventions

Local injection of lidocaine reduces muscle tremor

Lidocaine group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Thyroid papillary carcinoma
  • Lateral cervical lymph node metastasis
  • The diameter of the metastatic lymph nodes is less than 3cm
  • Without internal jugular vein invasion

You may not qualify if:

  • Lidocaine allergy sufferers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Medical University Union Hospital

Fuzhou, Fujian, 350001, China

RECRUITING

MeSH Terms

Conditions

Thyroid NeoplasmsHead and Neck NeoplasmsRecurrent Laryngeal Nerve InjuriesAccessory Nerve Injuries

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsEndocrine System DiseasesThyroid DiseasesLaryngeal Nerve InjuriesLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesVagus Nerve InjuriesCranial Nerve InjuriesCranial Nerve DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesAccessory Nerve Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
clinical Professor

Study Record Dates

First Submitted

May 8, 2018

First Posted

May 21, 2018

Study Start

May 1, 2018

Primary Completion

October 31, 2018

Study Completion

October 31, 2018

Last Updated

September 18, 2018

Record last verified: 2018-09

Locations